Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
09 Apr 20264 min read0 viewsINTERVENTIONAL Trial
GIST (Key Takeaways)
RECRUITING · INTERVENTIONAL · PREVENTION study · Preterm Delivery · Phase 3 · Enrollment 1800 · Sponsor: The George Washington University Biostatistics Center
Clinical Editorial
ClinicalTrials.gov published a clinical update in Infectious Disease on 09 Apr 2026. The item focuses on Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial. Open the detail page to review the full original feed content.
Source Reference
Read the full original publication from the source journal or publisher link below.